Medical weight management · GREENWOOD, IN
Semaglutide for Weight Management in Greenwood, IN
Managing weight can be complex, and it is not simply a matter of willpower. Semaglutide may be one option for some people as part of an individual plan that includes nutrition and physical activity.
How semaglutide supports weight management
Semaglutide is a GLP-1 receptor agonist, a medicine that acts on a hormone pathway involved in appetite. It can help some people feel less hungry or feel full sooner. Treatment works alongside a reduced-calorie eating plan and increased physical activity, rather than replacing them.
In one 68-week study of adults without diabetes, participants assigned to 2.4 mg of weekly semaglutide injection lost an average of 14.9% of their starting weight, compared with 2.4% in the placebo group. Both groups received lifestyle support. Results vary, and this study does not establish the results of a particular compounded preparation. Some weight may return after treatment stops.
Understanding the available types of semaglutide
Wegovy is an FDA-approved semaglutide medicine for long-term weight management in eligible patients, alongside a reduced-calorie diet and increased physical activity. It comes as an injection and as tablets. Ozempic also contains semaglutide, but it is approved for type 2 diabetes and certain related cardiovascular and kidney risk-reduction uses, not specifically for weight management. Prescribing an approved medicine for a use outside its FDA-approved label is called off-label prescribing and is not automatically illegal.
Compounded semaglutide may be considered for an individual medical need, subject to applicable law and clinical evaluation. Compounded preparations are not FDA approved or FDA-approved generics. Elevate Health works with reputable licensed compounding pharmacies that provide certificates of analysis and use third-party testing. Our pharmacy partners follow applicable federal and state requirements, including sterile compounding standards where relevant. Documentation can vary by product.
Who might be a candidate?
For adults, weight-management medication may be considered when body mass index (BMI) is 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure or type 2 diabetes. BMI is one part of the assessment. Your health history, goals, preferences, other treatments and medication coverage matter too.
Wegovy should not be used if you or a family member has had medullary thyroid carcinoma, a specific type of thyroid cancer, or if you have multiple endocrine neoplasia syndrome type 2. It is also contraindicated after a serious allergy to semaglutide or an ingredient in the product. Before treatment, discuss any history of pancreatitis, gallbladder or kidney problems, severe stomach-emptying problems, or diabetic eye disease. Tell your clinician about all medicines you take, including insulin, sulfonylureas and other GLP-1 medicines.
Side effects, pregnancy and breastfeeding
Nausea, vomiting, diarrhea and constipation are common, particularly as the dose increases. More serious concerns include pancreatitis, gallbladder problems and kidney injury related to dehydration. Seek urgent medical care for severe or persistent abdominal pain, and contact your clinician promptly if vomiting or diarrhea makes it hard to stay hydrated. Low blood sugar is a particular concern when semaglutide is taken with insulin or a sulfonylurea.
Tell your clinician if you are pregnant, breastfeeding or planning pregnancy. For weight management, Wegovy should be stopped when pregnancy is recognized and at least two months before a planned pregnancy. Breastfeeding is not recommended during treatment with Wegovy tablets; discuss the considerations for an injection with your clinician.
Making an informed treatment plan
A decision about medication should include a conversation about expected benefits, possible side effects, alternatives, out-of-pocket cost and the uncertainties that matter to you. Your clinician can review your health history and help you decide whether semaglutide or another approach is appropriate.
If medication is prescribed, ask which product and pharmacy will supply it, and review the dose, concentration, administration instructions and follow-up plan. Doses are generally increased gradually to improve tolerability. Your response, side effects and preferences help guide adjustments and whether to continue treatment.
Frequently asked questions
Is semaglutide right for everyone who wants to lose weight?
No. Candidacy depends on health history, BMI, other conditions and medicines, as well as your goals and preferences. A clinician can help you compare benefits, risks and alternatives.
Are Wegovy and compounded semaglutide the same?
No. Wegovy is FDA approved for specific uses. Compounded semaglutide is not FDA approved or an FDA-approved generic, and its formulation or concentration may differ. Ask about the exact product, pharmacy, dose and instructions. Compounded options are subject to applicable law and individual evaluation.
How is pharmacy compounding different from research-only peptides?
Legitimate pharmacy compounding involves preparing medication under applicable laws and professional oversight to meet a patient's needs. Products sold as research-use-only or not for human consumption are not the same as medication prepared for patient care. Elevate Health does not use grey-market peptides labeled for research use only or not for human consumption in patient care.
Is off-label prescribing illegal?
Not automatically. Off-label prescribing means a clinician prescribes an FDA-approved medicine for a use that is not included in its approved labeling. Whether a prescription is appropriate depends on the patient's circumstances, professional judgment and applicable law.
Will I keep the weight off if I stop?
Some weight may return after stopping weight-management medication. Discuss a long-term plan with your clinician, including nutrition, activity, side effects and whether continued treatment remains appropriate.
What if I am planning a pregnancy?
Discuss your plans before starting or continuing treatment. Wegovy for weight management should be stopped at least two months before a planned pregnancy. If pregnancy is recognized during weight-management treatment, stop Wegovy and contact your clinician promptly.
Care starts with a conversation
Have questions about your options? Our team can help you take the next step with an individualized consultation.
Visiting Elevate Health in Greenwood
Our office is in Greenwood, Indiana. We welcome patients traveling from Shelbyville, Greensburg and Indianapolis, and other Indiana communities. View our contact information and communities served.
Learn more
- Wegovy prescribing information
- FDA: Wegovy prescribing information, 2026
- FDA: Ozempic injection prescribing information, 2026
- New England Journal of Medicine: Semaglutide weight-management trial
- NIDDK: Prescription medications to treat overweight and obesity
- FDA: Compounding and the FDA, questions and answers
